← Eichor
Condition: Cisplatin Induced Ototoxicity Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Cisplatin Induced Ototoxicity

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Effect of Cancer Treatments on Speech Perception in Noise, Cognition, and Hearing-Related Quality of Life
Phase N/A · 1 location(s) · Turku University Hospital · NCT06551857Treatment of Radiation and Cisplatin Induced Toxicities with Tempol
Phase 2 · 9 location(s) · Matrix Biomed, Inc. · NCT03480971A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
Phase 3 · 108 location(s) · Children's Oncology Group · NCT05382338Efficacy of Sodium Thiosulfate and Mannitol in Reducing Ototoxicity in Adult Patients Receiving Cisplatin Chemotherapy
Phase 2 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT05129748Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial
Phase 2 · 1 location(s) · Siriraj Hospital · NCT07364747
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.